Involvement of tissue changes induced by neoadjuvant treatment in total mesorectal excision (TME): novel suggestions

Jin Cheon Kim1, Seong Ho Park2, Jihun Kim3

  • 1Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, 05505, Republic of Korea. jckim@amc.seoul.kr.

Abstract

Insights

Neoadjuvant treatment (NAT) for rectal cancer can alter tissues, potentially impacting the quality of total mesorectal excision (TME). Complete TME is crucial for better outcomes, but NAT may complicate its achievement.

Area of Science:

  • Colorectal surgery
  • Surgical oncology
  • Rectal cancer research

Background:

  • Limited research exists on morphological changes post-neoadjuvant treatment (NAT) and their impact on total mesorectal excision (TME) quality.
  • This study addresses the effect of NAT-induced tissue changes on TME quality and proposes an objective assessment method.

Purpose of the Study:

  • To evaluate the impact of NAT-associated tissue alterations on the quality of TME.
  • To propose a more objective method for assessing TME quality in rectal cancer surgery.

Main Methods:

  • 1322 rectal cancer patients undergoing robot-assisted surgery were analyzed.
  • Propensity-score matching created comparable groups of 402 patients who received NAT versus those who did not.

Main Results:

  • NAT independently decreased complete TME achievement (OR=2.056, p=0.017).
  • Tissue changes like tumor perforation and mucin pool were linked to incomplete TME.
  • Complete TME correlated with reduced local recurrence and improved 5-year disease-free survival (DFS), though NAT in complete TME cases showed lower 5-year DFS.

Conclusions:

  • NAT-induced tissue changes can compromise complete TME quality, potentially explaining NAT's limited impact on overall survival.
  • A simplified TME grading system of 'complete' versus 'inappropriate' is suggested over the traditional three-tier system.